HealthDay (8/4, Solomon) reported, “Approximately one-third of patients 50 years or younger with sudden cardiac death (SCD) have positive toxicology for illicit drugs,” investigators concluded in findings published online ahead of print in the journal Heart Rhythm. The study, which “identified rates of illicit drug use in younger patients with SCD using data from 523 patients with confirmed out-of-hospital cardiac arrest (ages 18 to 50 years) with a toxicological assessment (April 2019 to April 2021),” revealed that “32.5% of patients had either positive toxicology for illicit drugs (138 patients) or negative toxicology but reported regular drug use (32 patients).”

Related Links:

— “Illicit Drug Use Seen in One-Third of Sudden Cardiac Deaths in Younger Adults,”Lori Solomon, HealthDay, August 4, 2023

The New York Times (8/4, A1, Belluck) reported the FDA has approved Zurzuvae (zuranolone), “the first pill for postpartum depression, a milestone considered likely to increase recognition and treatment of” the condition. According to the Times, “Clinical trial data show the pill works quickly, beginning to ease depression in as little as three days, significantly faster than general antidepressants, which can take two weeks or longer to have an effect.”

NBC News (8/4, Bendix, Kopf) reported, “The medication…is taken daily for two weeks.” Researchers found, “in a pair of clinical trials involving women who experienced severe depression after having a baby, the drug improved symptoms – such as anxiety, difficulty sleeping, loss of pleasure, low energy, guilt or social withdrawal – as early as three days after taking the first pill.”

Also covering the story were CNN (8/4, Howard), Reuters (8/5), The Hill (8/4, Robertson), the AP (8/4, Perrone), HealthDay (8/5, Mann), MedPage Today (8/4, Monaco), and Medscape (8/4, Marcus, Subscription Publication).

Related Links:

— “FDA approves first pill for postpartum depression,”Aria Bendix and Marina Kopf, NBC News, August 4, 2023

According to Healio (8/3, Herpen), “rates of new-onset mental health conditions were higher in U.S. soldiers with a history of military-related traumatic brain injury” (TBI), “while increased risk for suicide was both directly and indirectly associated with TBI history.” Investigators arrived at this conclusion after having examined data on “more than 860,000 U.S. soldiers, including more than 108,000 with history of” TBI. The findings were published online July 31 in JAMA Network Open.

Related Links:

— “Rates of new-onset mental health conditions higher in US soldiers with history of TBI,”Robert Herpen, Healio, August 3, 2023

Psychiatric News (8/4) reported, “Suicide is the most common cause of death in patients who have schizophrenia spectrum disorders,” researchers concluded after having “analyzed data from the OPUS I study, a randomized controlled trial of 578 patients experiencing their first episode of psychosis.” The findingswere published online Aug. 1 in the Schizophrenia Bulletin.

Related Links:

— “Suicide Most Common Cause of Death in People With Schizophrenia, Study Finds, Psychiatric News, August 4, 2023

Nexstar (8/5, Suter) reported, “A recent study” published online July 30 in The Lancet Psychiatry “found that by the age of 75 about half of all people will develop a mental” illness. Included in the study were “over 150,000 respondents aged 18 and older from 29 countries between 2001 and 2022.” The study also revealed that “different disorders more commonly” affected “different genders than others.”

HealthDay (8/4, Solomon) reported, “Alcohol use disorder and major depressive disorder were the two most prevalent disorders for male respondents, while major depressive disorder and specific phobia were most prevalent for female respondents,” according to the study.

Related Links:

— “At least half of all people likely to develop mental health disorders before 75: study,”Tara Suter, Nexstar, August 5, 2023

HealthDay (8/3, Murez) reports a rise in cannabis use and progression to cannabis use disorder among non-college young adults post-legalization, according to a study using data from the National Survey on Drug Use and Health. A statement by the study’s co-author encourages continued monitoring of “changes in prevalence of cannabis use, frequent cannabis use and cannabis use disorder among young adults while the cannabis landscape in the U.S. continues to evolve.” The “research doesn’t address why these changes are occurring,” but another co-author suggests changes in public beliefs about cannabis use and increased drug potency might be influencing the trend. The findingswere published in the American Journal of Preventive Medicine.

Related Links:

— “Marijuana Use by Youth: After Legalization, Education Seems to Matter,”Cara Murez, HealthDay, August 3, 2023

Psychiatric News (8/3) reports, “Current field sobriety tests administered by trained law enforcement officers may not be enough to identify drivers who are driving under the influence of cannabis,” researchers concluded in the findings of a 184-participant, “double-blind, placebo-controlled trial” published online Aug. 2 in JAMA Psychiatry.

Related Links:

— “Trained Officers Using Current Field Sobriety Tests May Misclassify Cannabis-Impaired Drivers, Psychiatric News, August 3, 2023

According to NBC News (8/3, Lovelace), a research letter published online June 5 in JAMA Pediatrics revealed that “fewer than one in three mental health facilities in the United States offered services specifically designed for LGBTQ patients – such as coming out support, counseling on sexual orientation and gender-affirming therapy – for children and adolescents in 2020.” What’s more, “on a per capita basis, all 50 states had fewer than 10 facilities with LGBTQ services per 100,000 children.” The study’s lead author “said the number of mental health facilities in the U.S. that are trained to serve LGBTQ youth has barely budged over a six-year period, increasing from 25% of all facilities in 2014 to just 28% in 2020.”

Related Links:

— “LGBTQ teens often struggle to find mental health care tailored to them,”Berkeley Lovelace Jr., NBC News, August 3, 2023

HealthDay (8/3, Solomon) reports, “Women with a history of infertility are more likely to experience more severe menopausal symptoms at midlife,” researchers concluded in an analysis that “included 695 midlife women participants in Project Viva” who “were enrolled during 1999 to 2002 during pregnancy and were followed for 18 years (age 45 years or older or reporting ≥12 months of amenorrhea at the midlife visit).” The study revealed “an association between a history of infertility and increased odds of depression and sleep symptoms in midlife.” The findings were published online in the journal Menopause.

Related Links:

— “Infertility Tied to More Severe Menopause Symptoms in Midlife,”Lori Solomon, HealthDay, August 3, 2023

mHealth Intelligence (8/2, Melchionna) reports, “A…study found that telehealth use increased between 2019 and 2021. Various patient- and [practitioner-level] factors such as age, area of residence, and type of [clinician] practice setting had a significant impact on outcomes.” This “high level of satisfaction with telehealth also indicates the need for further reimbursement.” The findings were published in JCO Oncology Practice.

Related Links:

— “Age, Residence Type, and Practice Setting Affect Telehealth Use,” Mark Melchionna, mHealth Intelligence, August 2, 2023